- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Netupitant + palonosetron – November 2015
Netupitant + palonosetron: netupitant 300 mg + palonosetron 0.5 mg, fixed-dose combination capsule; Akynzeo®
Last updated
4 March 2016